APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor Concentrates

Compare research editions
View pricing & licenses

Selected research

Industry Research

Coagulation Factor Concentrates Industry Research Report 2026

22 December 2025124 pages

Choose your research edition.

Industry ResearchCoagulation Factor Concentrates Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor Concentrates Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Coagulation Factor Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor Concentrates Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor Concentrates Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Coagulation Factor Concentrates market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Coagulation Factor Concentrates is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Coagulation Factor Concentrates is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor Concentrates is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Coagulation Factor Concentrates include Bio Product Laboratory (UK), Biotest (Germany), CSL (Australia), Green Cross Corporation (South Korea), Grifols (Spain), Japan Blood Products Organization, China Biologic Products (China), Kedrion (Italy), LFB (France) and Octapharma (Switzerland), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Coagulation Factor Concentrates market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Coagulation Factor Concentrates Market by Company

Bio Product Laboratory (UK)

Biotest (Germany)

CSL (Australia)

Green Cross Corporation (South Korea)

Grifols (Spain)

Japan Blood Products Organization, China Biologic Products (China)

Kedrion (Italy)

LFB (France)

Octapharma (Switzerland)

Sanquin (Netherlands)

Shire (Ireland)

Shanghai RAAS Blood Products (China)

Coagulation Factor Concentrates Segment by Type

Factor XIII

Factor VIII

Factor IX

Fibrinogen Concentrates

Prothrombin Complex Concentrates

Von Willebrand Factor

Coagulation Factor Concentrates Segment by Application

Pulmonology

Rheumatology

Immunology

Neurology

Hematology

Hemato-Oncology

Critical Care

Others

Coagulation Factor Concentrates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor Concentrates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Coagulation Factor Concentrates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Coagulation Factor Concentrates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Coagulation Factor Concentrates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Coagulation Factor Concentrates Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Coagulation Factor Concentrates Sales (k units) of Manufacturers (2021-2026) Table 7. Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2021-2026) Table 8. Global Coagulation Factor Concentrates Revenue of Manufacturers (2021-2026) Table 9. Global Coagulation Factor Concentrates Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Coagulation Factor Concentrates Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Coagulation Factor Concentrates Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Coagulation Factor Concentrates, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Coagulation Factor Concentrates, Product Type & Application Table 14. Global Coagulation Factor Concentrates Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Coagulation Factor Concentrates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bio Product Laboratory (UK) Company Information Table 19. Bio Product Laboratory (UK) Business Overview Table 20. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio Table 22. Bio Product Laboratory (UK) Recent Developments Table 23. Biotest (Germany) Company Information Table 24. Biotest (Germany) Business Overview Table 25. Biotest (Germany) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Biotest (Germany) Coagulation Factor Concentrates Product Portfolio Table 27. Biotest (Germany) Recent Developments Table 28. CSL (Australia) Company Information Table 29. CSL (Australia) Business Overview Table 30. CSL (Australia) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. CSL (Australia) Coagulation Factor Concentrates Product Portfolio Table 32. CSL (Australia) Recent Developments Table 33. Green Cross Corporation (South Korea) Company Information Table 34. Green Cross Corporation (South Korea) Business Overview Table 35. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio Table 37. Green Cross Corporation (South Korea) Recent Developments Table 38. Grifols (Spain) Company Information Table 39. Grifols (Spain) Business Overview Table 40. Grifols (Spain) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Grifols (Spain) Coagulation Factor Concentrates Product Portfolio Table 42. Grifols (Spain) Recent Developments Table 43. Japan Blood Products Organization, China Biologic Products (China) Company Information Table 44. Japan Blood Products Organization, China Biologic Products (China) Business Overview Table 45. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio Table 47. Japan Blood Products Organization, China Biologic Products (China) Recent Developments Table 48. Kedrion (Italy) Company Information Table 49. Kedrion (Italy) Business Overview Table 50. Kedrion (Italy) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio Table 52. Kedrion (Italy) Recent Developments Table 53. LFB (France) Company Information Table 54. LFB (France) Business Overview Table 55. LFB (France) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. LFB (France) Coagulation Factor Concentrates Product Portfolio Table 57. LFB (France) Recent Developments Table 58. Octapharma (Switzerland) Company Information Table 59. Octapharma (Switzerland) Business Overview Table 60. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio Table 62. Octapharma (Switzerland) Recent Developments Table 63. Sanquin (Netherlands) Company Information Table 64. Sanquin (Netherlands) Business Overview Table 65. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio Table 67. Sanquin (Netherlands) Recent Developments Table 68. Shire (Ireland) Company Information Table 69. Shire (Ireland) Business Overview Table 70. Shire (Ireland) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Shire (Ireland) Coagulation Factor Concentrates Product Portfolio Table 72. Shire (Ireland) Recent Developments Table 73. Shanghai RAAS Blood Products (China) Company Information Table 74. Shanghai RAAS Blood Products (China) Business Overview Table 75. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio Table 77. Shanghai RAAS Blood Products (China) Recent Developments Table 78. Global Coagulation Factor Concentrates Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Coagulation Factor Concentrates Sales by Region (2021-2026) & (k units) Table 80. Global Coagulation Factor Concentrates Sales Market Share by Region (2021-2026) Table 81. Global Coagulation Factor Concentrates Sales by Region (2027-2032) & (k units) Table 82. Global Coagulation Factor Concentrates Sales Market Share by Region (2027-2032) Table 83. Global Coagulation Factor Concentrates Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Coagulation Factor Concentrates Revenue Market Share by Region (2021-2026) Table 85. Global Coagulation Factor Concentrates Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Coagulation Factor Concentrates Revenue Market Share by Region (2027-2032) Table 87. North America Coagulation Factor Concentrates Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 89. North America Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 90. North America Coagulation Factor Concentrates Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Coagulation Factor Concentrates Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Coagulation Factor Concentrates Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 94. Europe Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 95. Europe Coagulation Factor Concentrates Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Coagulation Factor Concentrates Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Coagulation Factor Concentrates Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 99. Asia Pacific Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 100. Asia Pacific Coagulation Factor Concentrates Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Coagulation Factor Concentrates Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Coagulation Factor Concentrates Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 104. South America Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 105. South America Coagulation Factor Concentrates Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Coagulation Factor Concentrates Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Coagulation Factor Concentrates Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Coagulation Factor Concentrates Sales by Country (2021-2026) & (k units) Table 109. Middle East and Africa Coagulation Factor Concentrates Sales by Country (2027-2032) & (k units) Table 110. Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Coagulation Factor Concentrates Sales by Type (2021-2026) & (k units) Table 113. Global Coagulation Factor Concentrates Sales by Type (2027-2032) & (k units) Table 114. Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2026) Table 115. Global Coagulation Factor Concentrates Sales Market Share by Type (2027-2032) Table 116. Global Coagulation Factor Concentrates Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Coagulation Factor Concentrates Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2026) Table 119. Global Coagulation Factor Concentrates Revenue Market Share by Type (2027-2032) Table 120. Global Coagulation Factor Concentrates Price by Type (2021-2026) & (US$/unit) Table 121. Global Coagulation Factor Concentrates Price by Type (2027-2032) & (US$/unit) Table 122. Global Coagulation Factor Concentrates Sales by Application (2021-2026) & (k units) Table 123. Global Coagulation Factor Concentrates Sales by Application (2027-2032) & (k units) Table 124. Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2026) Table 125. Global Coagulation Factor Concentrates Sales Market Share by Application (2027-2032) Table 126. Global Coagulation Factor Concentrates Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Coagulation Factor Concentrates Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2026) Table 129. Global Coagulation Factor Concentrates Revenue Market Share by Application (2027-2032) Table 130. Global Coagulation Factor Concentrates Price by Application (2021-2026) & (US$/unit) Table 131. Global Coagulation Factor Concentrates Price by Application (2027-2032) & (US$/unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Coagulation Factor Concentrates Distributors List Table 135. Coagulation Factor Concentrates Customers List Table 136. Coagulation Factor Concentrates Industry Trends Table 137. Coagulation Factor Concentrates Industry Drivers Table 138. Coagulation Factor Concentrates Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Coagulation Factor Concentrates Product Image Figure 5. Global Coagulation Factor Concentrates Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Coagulation Factor Concentrates Market Size (2021-2032) & (US$ Million) Figure 7. Global Coagulation Factor Concentrates Sales (2021-2032) & (k units) Figure 8. Global Coagulation Factor Concentrates Average Price (US$/unit) & (2021-2032) Figure 9. Factor XIII Product Image Figure 10. Factor VIII Product Image Figure 11. Factor IX Product Image Figure 12. Fibrinogen Concentrates Product Image Figure 13. Prothrombin Complex Concentrates Product Image Figure 14. Von Willebrand Factor Product Image Figure 15. Pulmonology Product Image Figure 16. Rheumatology Product Image Figure 17. Immunology Product Image Figure 18. Neurology Product Image Figure 19. Hematology Product Image Figure 20. Hemato-Oncology Product Image Figure 21. Critical Care Product Image Figure 22. Others Product Image Figure 23. Global Coagulation Factor Concentrates Revenue Share by Manufacturers in 2025 Figure 24. Global Manufacturers of Coagulation Factor Concentrates, Manufacturing Sites & Headquarters Figure 25. Global Top 5 and 10 Coagulation Factor Concentrates Players Market Share by Revenue in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Coagulation Factor Concentrates Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 28. Global Coagulation Factor Concentrates Sales by Region in 2025 Figure 29. Global Coagulation Factor Concentrates Revenue by Region in 2025 Figure 30. North America Coagulation Factor Concentrates Market Size by Country in 2025 Figure 31. North America Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 32. North America Coagulation Factor Concentrates Revenue Market Share by Country (2021-2032) Figure 33. United States Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Mexico Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Europe Coagulation Factor Concentrates Market Size by Country in 2025 Figure 37. Europe Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 38. Europe Coagulation Factor Concentrates Revenue Market Share by Country (2021-2032) Figure 39. Germany Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. France Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. U.K. Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Italy Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Russia Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Spain Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Netherlands Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Switzerland Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Sweden Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Poland Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Asia Pacific Coagulation Factor Concentrates Market Size by Country in 2025 Figure 50. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 51. Asia Pacific Coagulation Factor Concentrates Revenue Market Share by Country (2021-2032) Figure 52. China Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Japan Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South Korea Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. India Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Australia Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Taiwan Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Southeast Asia Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Southeast Asia Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South America Coagulation Factor Concentrates Market Size by Country in 2025 Figure 61. South America Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 62. South America Coagulation Factor Concentrates Revenue Market Share by Country (2021-2032) Figure 63. Brazil Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Argentina Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Chile Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Middle East and Africa Coagulation Factor Concentrates Market Size by Country in 2025 Figure 67. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Country (2021-2032) Figure 68. Middle East and Africa Coagulation Factor Concentrates Revenue Market Share by Country (2021-2032) Figure 69. Egypt Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. South Africa Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Israel Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. Türkiye Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 73. GCC Countries Coagulation Factor Concentrates Revenue Growth Rate (2021-2032) & (US$ Million) Figure 74. Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2032) Figure 75. Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2032) Figure 76. Global Coagulation Factor Concentrates Price (US$/unit) by Type (2021-2032) Figure 77. Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2032) Figure 78. Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2032) Figure 79. Global Coagulation Factor Concentrates Price (US$/unit) by Application (2021-2032) Figure 80. Coagulation Factor Concentrates Value Chain Figure 81. Coagulation Factor Concentrates Production Mode & Process Figure 82. Direct Comparison with Distribution Share Figure 83. Distributors Profiles Figure 84. Coagulation Factor Concentrates Industry Opportunities and Challenges

Scope & coverage.

Types
  • Factor XIII
  • Factor VIII
  • Factor IX
  • Fibrinogen Concentrates
  • Prothrombin Complex Concentrates
  • Von Willebrand Factor
Applications
  • Pulmonology
  • Rheumatology
  • Immunology
  • Neurology
  • Hematology
  • Hemato-Oncology
  • Critical Care
  • Others
Companies covered
  • Bio Product Laboratory (UK)
  • Biotest (Germany)
  • CSL (Australia)
  • Green Cross Corporation (South Korea)
  • Grifols (Spain)
  • Japan Blood Products Organization, China Biologic Products (China)
  • Kedrion (Italy)
  • LFB (France)
  • Octapharma (Switzerland)
  • Sanquin (Netherlands)
  • Shire (Ireland)
  • Shanghai RAAS Blood Products (China)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Coagulation Factor Concentrates Market Size (2021-2032)
  4. 2.2.2 Global Coagulation Factor Concentrates Sales (2021-2032)
  5. 2.2.3 Global Coagulation Factor Concentrates Market Average Price (2021-2032)
  6. 2.3 Coagulation Factor Concentrates by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Factor XIII
  9. 2.3.3 Factor VIII
  10. 2.3.4 Factor IX
  11. 2.3.5 Fibrinogen Concentrates
  12. 2.3.6 Prothrombin Complex Concentrates
  13. 2.3.7 Von Willebrand Factor
  14. 2.4 Coagulation Factor Concentrates by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Pulmonology
  17. 2.4.3 Rheumatology
  18. 2.4.4 Immunology
  19. 2.4.5 Neurology
  20. 2.4.6 Hematology
  21. 2.4.7 Hemato-Oncology
  22. 2.4.8 Critical Care
  23. 2.4.9 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Coagulation Factor Concentrates Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Coagulation Factor Concentrates Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Coagulation Factor Concentrates Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Coagulation Factor Concentrates Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Coagulation Factor Concentrates Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Coagulation Factor Concentrates, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Coagulation Factor Concentrates, Product Type & Application
  8. 3.8 Global Manufacturers of Coagulation Factor Concentrates, Established Date
  9. 3.9 Global Coagulation Factor Concentrates Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bio Product Laboratory (UK)
  2. 4.1.1 Bio Product Laboratory (UK) Company Information
  3. 4.1.2 Bio Product Laboratory (UK) Business Overview
  4. 4.1.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio
  6. 4.1.5 Bio Product Laboratory (UK) Recent Developments
  7. 4.2 Biotest (Germany)
  8. 4.2.1 Biotest (Germany) Company Information
  9. 4.2.2 Biotest (Germany) Business Overview
  10. 4.2.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Biotest (Germany) Coagulation Factor Concentrates Product Portfolio
  12. 4.2.5 Biotest (Germany) Recent Developments
  13. 4.3 CSL (Australia)
  14. 4.3.1 CSL (Australia) Company Information
  15. 4.3.2 CSL (Australia) Business Overview
  16. 4.3.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CSL (Australia) Coagulation Factor Concentrates Product Portfolio
  18. 4.3.5 CSL (Australia) Recent Developments
  19. 4.4 Green Cross Corporation (South Korea)
  20. 4.4.1 Green Cross Corporation (South Korea) Company Information
  21. 4.4.2 Green Cross Corporation (South Korea) Business Overview
  22. 4.4.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio
  24. 4.4.5 Green Cross Corporation (South Korea) Recent Developments
  25. 4.5 Grifols (Spain)
  26. 4.5.1 Grifols (Spain) Company Information
  27. 4.5.2 Grifols (Spain) Business Overview
  28. 4.5.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Grifols (Spain) Coagulation Factor Concentrates Product Portfolio
  30. 4.5.5 Grifols (Spain) Recent Developments
  31. 4.6 Japan Blood Products Organization, China Biologic Products (China)
  32. 4.6.1 Japan Blood Products Organization, China Biologic Products (China) Company Information
  33. 4.6.2 Japan Blood Products Organization, China Biologic Products (China) Business Overview
  34. 4.6.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio
  36. 4.6.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments
  37. 4.7 Kedrion (Italy)
  38. 4.7.1 Kedrion (Italy) Company Information
  39. 4.7.2 Kedrion (Italy) Business Overview
  40. 4.7.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio
  42. 4.7.5 Kedrion (Italy) Recent Developments
  43. 4.8 LFB (France)
  44. 4.8.1 LFB (France) Company Information
  45. 4.8.2 LFB (France) Business Overview
  46. 4.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 LFB (France) Coagulation Factor Concentrates Product Portfolio
  48. 4.8.5 LFB (France) Recent Developments
  49. 4.9 Octapharma (Switzerland)
  50. 4.9.1 Octapharma (Switzerland) Company Information
  51. 4.9.2 Octapharma (Switzerland) Business Overview
  52. 4.9.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio
  54. 4.9.5 Octapharma (Switzerland) Recent Developments
  55. 4.10 Sanquin (Netherlands)
  56. 4.10.1 Sanquin (Netherlands) Company Information
  57. 4.10.2 Sanquin (Netherlands) Business Overview
  58. 4.10.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio
  60. 4.10.5 Sanquin (Netherlands) Recent Developments
  61. 4.11 Shire (Ireland)
  62. 4.11.1 Shire (Ireland) Company Information
  63. 4.11.2 Shire (Ireland) Business Overview
  64. 4.11.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Shire (Ireland) Coagulation Factor Concentrates Product Portfolio
  66. 4.11.5 Shire (Ireland) Recent Developments
  67. 4.12 Shanghai RAAS Blood Products (China)
  68. 4.12.1 Shanghai RAAS Blood Products (China) Company Information
  69. 4.12.2 Shanghai RAAS Blood Products (China) Business Overview
  70. 4.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio
  72. 4.12.5 Shanghai RAAS Blood Products (China) Recent Developments
5 Global Coagulation Factor Concentrates Market Scenario by Region
  1. 5.1 Global Coagulation Factor Concentrates Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Coagulation Factor Concentrates Sales by Region: 2021-2032
  3. 5.2.1 Global Coagulation Factor Concentrates Sales by Region: 2021-2026
  4. 5.2.2 Global Coagulation Factor Concentrates Sales by Region: 2027-2032
  5. 5.3 Global Coagulation Factor Concentrates Revenue by Region: 2021-2032
  6. 5.3.1 Global Coagulation Factor Concentrates Revenue by Region: 2021-2026
  7. 5.3.2 Global Coagulation Factor Concentrates Revenue by Region: 2027-2032
  8. 5.4 North America Coagulation Factor Concentrates Market Facts & Figures by Country
  9. 5.4.1 North America Coagulation Factor Concentrates Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Coagulation Factor Concentrates Sales by Country (2021-2032)
  11. 5.4.3 North America Coagulation Factor Concentrates Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Coagulation Factor Concentrates Market Facts & Figures by Country
  16. 5.5.1 Europe Coagulation Factor Concentrates Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Coagulation Factor Concentrates Sales by Country (2021-2032)
  18. 5.5.3 Europe Coagulation Factor Concentrates Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Coagulation Factor Concentrates Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Coagulation Factor Concentrates Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Coagulation Factor Concentrates Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Coagulation Factor Concentrates Market Facts & Figures by Country
  41. 5.7.1 South America Coagulation Factor Concentrates Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Coagulation Factor Concentrates Sales by Country (2021-2032)
  43. 5.7.3 South America Coagulation Factor Concentrates Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Coagulation Factor Concentrates Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Coagulation Factor Concentrates Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Coagulation Factor Concentrates Sales by Type (2021-2032)
  2. 6.1.1 Global Coagulation Factor Concentrates Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Coagulation Factor Concentrates Sales Market Share by Type (2021-2032)
  4. 6.2 Global Coagulation Factor Concentrates Revenue by Type (2021-2032)
  5. 6.2.1 Global Coagulation Factor Concentrates Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Coagulation Factor Concentrates Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Coagulation Factor Concentrates Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Coagulation Factor Concentrates Sales by Application (2021-2032)
  2. 7.1.1 Global Coagulation Factor Concentrates Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Coagulation Factor Concentrates Sales Market Share by Application (2021-2032)
  4. 7.2 Global Coagulation Factor Concentrates Revenue by Application (2021-2032)
  5. 7.2.1 Global Coagulation Factor Concentrates Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Coagulation Factor Concentrates Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Coagulation Factor Concentrates Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Coagulation Factor Concentrates Value Chain Analysis
  2. 8.1.1 Coagulation Factor Concentrates Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Coagulation Factor Concentrates Production Mode & Process
  5. 8.2 Coagulation Factor Concentrates Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Coagulation Factor Concentrates Distributors
  8. 8.2.3 Coagulation Factor Concentrates Customers
9 Global Coagulation Factor Concentrates Analyzing Market Dynamics
  1. 9.1 Coagulation Factor Concentrates Industry Trends
  2. 9.2 Coagulation Factor Concentrates Industry Drivers
  3. 9.3 Coagulation Factor Concentrates Industry Opportunities and Challenges
  4. 9.4 Coagulation Factor Concentrates Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst